Background illustration for clinical trials search

Paid Clinical Trials Providence

Discover 482 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: Providence RI, North Massapequa NY, Lebanon NH,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06588855

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Providence RI, Boston MA, North Massapequa NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
Featured

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Providence RI, The Bronx NY, Montreal, Toronto,
Sponsor: Hoffmann-La Roche

Sex: Male

Age: 18+

Code: NCT07287150

Phase2, Recruiting
Featured

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Providence RI, New Haven CT, Danbury CT, Norwalk CT,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase2, Recruiting
FeaturedNew

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: Providence RI, New York NY, Westlake OH, Englewood OH,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Providence RI, North Worcester MA, Lebanon NH,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase3, Recruiting
Featured

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for
Alzheimers Disease
Location: Providence RI, Newton MA, Boston MA, Watertown MA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase3, Recruiting
Featured

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

for
Alzheimers Disease
Location: Providence RI, Newton MA, Boston MA, The Bronx NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07169578

Phase3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: East Greenwich RI, Burlington MA, Carmel NY, Albany NY,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase3, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: East Greenwich RI, Framingham MA, Burlington MA,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase3, Recruiting
Active & Responsive

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Providence RI, Winchester MA, Burlington MA, Peabody MA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05929768

Phase3, Recruiting
Active & Responsive

Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training

for
Alcohol Use Disorder
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 13 - 19

Code: NCT07713251

Recruiting
Active & Responsive

iPAWS: Improving Pain Management After Wisdom Tooth Extraction Surgery

for
Pain, Postoperative, Substance Use
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 15 - 20

Code: NCT07731295

Recruiting
Active & Responsive

Teen Health Choices & Wellness

for
Health Behavior, Wellness, Psychological, Substance Use
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 13 - 16

Code: NCT06822569

Recruiting
Active & Responsive

A Study of Brenipatide in Participants With Opioid Use Disorder

for
Opioid Use Disorder
Location: Providence RI, Boston MA, Watertown MA, The Bronx NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07420283

Phase2, Recruiting
Active & Responsive

Cognitive Strategies for Weight Loss

for
Obesity
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 70

Code: NCT05799846

Recruiting
Active & Responsive

Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment

for
Obesity & Overweight
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 70

Code: NCT07228130

Recruiting
Active & Responsive

Optimizing an Online Behavioral Weight Loss Intervention and Novel Culturally Tailored Components for Sexual Minority Women

for
Obesity
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: Female

Age: 18 - 70

Code: NCT05775497

Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Providence RI, Boston MA, New York NY, Newark NJ,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & Responsive

Cannabis' Impact on Alcohol Consumption

for
Alcohol Drinking, Cannabis Use, Cannabis, Alcohol Use Disorder
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 21 - 50

Code: NCT05389930

Phase2, Recruiting